The safety of YONDELIS® was evaluated in 755 patients
YONDELIS® was studied in 6 open-label, single-arm trials, in which 377 patients received YONDELIS®, and 1 open-label, randomized, active-controlled clinical trial, in which 378 patients received YONDELIS®. In these trials, 26% (197) of patients were treated with YONDELIS® for 6 months or longer, and 8% (57) were treated with YONDELIS® for 1 year or longer.1